These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26108913)

  • 1. Oseltamivir for the treatment of H1N1 influenza during pregnancy.
    Beigi RH; Pillai VC; Venkataramanan R; Caritis SN
    Clin Pharmacol Ther; 2015 Oct; 98(4):403-5. PubMed ID: 26108913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oseltamivir for influenza in pregnancy.
    Beigi RH; Venkataramanan R; Caritis SN
    Semin Perinatol; 2014 Dec; 38(8):503-7. PubMed ID: 25281358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influenza A, pregnancy and neuraminidase inhibitors].
    Montané E; Lecumberri J; Pedro-Botet ML
    Med Clin (Barc); 2011 May; 136(15):688-93. PubMed ID: 20416906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women.
    Tanaka T; Nakajima K; Murashima A; Garcia-Bournissen F; Koren G; Ito S
    CMAJ; 2009 Jul; 181(1-2):55-8. PubMed ID: 19528139
    [No Abstract]   [Full Text] [Related]  

  • 5. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa.
    Besselaar TG; Naidoo D; Buys A; Gregory V; McAnerney J; Manamela JM; Blumberg L; Schoub BD
    Emerg Infect Dis; 2008 Nov; 14(11):1809-10. PubMed ID: 18976580
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.
    Jefferson T; Jones M; Doshi P; Del Mar C
    BMJ; 2009 Dec; 339():b5106. PubMed ID: 19995812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
    Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global transmission of oseltamivir-resistant influenza.
    Moscona A
    N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250
    [No Abstract]   [Full Text] [Related]  

  • 9. Pregnancy outcome following maternal use of zanamivir or oseltamivir during the 2009 influenza A/H1N1 pandemic: a national prospective surveillance study.
    Dunstan HJ; Mill AC; Stephens S; Yates LM; Thomas SH
    BJOG; 2014 Jun; 121(7):901-6. PubMed ID: 24602087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oseltamivir in neonates, infants and young children: a focus on clinical pharmacology.
    Karadag-Oncel E; Ceyhan M
    Infect Disord Drug Targets; 2013 Feb; 13(1):15-24. PubMed ID: 23675923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of oseltamivir in pregnancy: a review of preclinical and clinical data.
    Donner B; Niranjan V; Hoffmann G
    Drug Saf; 2010 Aug; 33(8):631-42. PubMed ID: 20635821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
    Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
    Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oseltamivir use in adolescents and adults: clinical and economic considerations.
    Yin JK; Heron L; Salkeld G; Rashid H; Booy R
    Infect Disord Drug Targets; 2013 Feb; 13(1):53-8. PubMed ID: 23675927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The truth about Tamiflu? Neuraminidase inhibitors in pandemic A/H1N1 flu.
    Weber JT; Nicoll A; Bridges CB; Ciancio BC
    BMJ; 2010 Jan; 340():c130. PubMed ID: 20071425
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuraminidase inhibitors for preventing and treating influenza in children.
    Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
    Cochrane Database Syst Rev; 2012 Jan; 1():CD002744. PubMed ID: 22258949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).
    Wang K; Shun-Shin M; Gill P; Perera R; Harnden A
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD002744. PubMed ID: 22513907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oseltamivir for control of influenza at mass gatherings.
    Tashani M; Rashid H; Ridda I; Heron L; Memish ZA; Haworth E; Booy R
    Infect Disord Drug Targets; 2013 Feb; 13(1):46-52. PubMed ID: 23675926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuraminidase inhibitors and high risk of influenza complications: considered and widely-supported recommendations].
    van Dissel JT; Coutinho RA; van der Sande MA
    Ned Tijdschr Geneeskd; 2009; 153():B486. PubMed ID: 20051160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data.
    Heneghan CJ; Onakpoya I; Jones MA; Doshi P; Del Mar CB; Hama R; Thompson MJ; Spencer EA; Mahtani KR; Nunan D; Howick J; Jefferson T
    Health Technol Assess; 2016 May; 20(42):1-242. PubMed ID: 27246259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.